Literature DB >> 11819346

Immune response against HBsAg vaccine.

Maria Cristina Honorati, Andrea Facchini.   

Abstract

Year:  1998        PMID： 11819346      PMCID： PMC4723429          DOI： 10.3748/wjg.v4.i6.464

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  17 in total

1.  Cellular response and anti-HBs synthesis in vitro after vaccination with yeast-derived recombinant hepatitis vaccine.

Authors:  A Degrassi; E Mariani; M C Honorati; P Roda; R Miniero; M Capelli; A Facchini
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine.

Authors:  M C Honorati; P Dolzani; E Mariani; A Piacentini; G Lisignoli; C Ferrari; A Facchini
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

3.  Hepatitis B vaccines--to switch or not to switch.

Authors:  F B Hollinger
Journal:  JAMA       Date:  1987-05-15       Impact factor: 56.272

4.  A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B.

Authors:  M C Honorati; A Palareti; P Dolzani; C A Busachi; R Rizzoli; A Facchini
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

5.  Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection.

Authors:  V Barnaba; A Franco; A Alberti; C Balsano; R Benvenuto; F Balsano
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

6.  Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine.

Authors:  M C Honorati; R M Borzì; P Dolzani; S Toneguzzi; A Facchini
Journal:  Int J Clin Lab Res       Date:  1997

7.  Biological parameters influencing the immunological response to plasma derived and recombinant hepatitis B vaccines.

Authors:  M C Honorati; E Mariani; P Dolzani; A Facchini
Journal:  Ann Ist Super Sanita       Date:  1996       Impact factor: 1.663

8.  HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.

Authors:  R Nayersina; P Fowler; S Guilhot; G Missale; A Cerny; H J Schlicht; A Vitiello; R Chesnut; J L Person; A G Redeker; F V Chisari
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

9.  Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses.

Authors:  W Böhm; T Mertens; R Schirmbeck; J Reimann
Journal:  Vaccine       Date:  1998 May-Jun       Impact factor: 3.641

10.  Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.

Authors:  V Barnaba; A Franco; M Paroli; R Benvenuto; G De Petrillo; V L Burgio; I Santilio; C Balsano; M S Bonavita; G Cappelli
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422
View more
  3 in total

1.  Expression of RNase H of human hepatitis B virus polymerase in Escherichia coli.

Authors:  Hong Cheng; Hui-Zhong Zhang; Wan-An Shen; Yan-Fang Liu; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

2.  Antibody and immune memory persistence post infant hepatitis B vaccination.

Authors:  Shuaibu A Hudu; Yasmin A Malik; Mohd Taib Niazlin; Nabil S Harmal; Ariza Adnan; Ahmed S Alshrari; Zamberi Sekawi
Journal:  Patient Prefer Adherence       Date:  2013-09-27       Impact factor: 2.711

Review 3.  Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines.

Authors:  Kara-Lee Aves; Louise Goksøyr; Adam F Sander
Journal:  Viruses       Date:  2020-02-06       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.